Studies of association of AGPAT6 variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes

详细信息    查看全文

• 作者：Lena S?nder Snogdal (1) (2)
  Niels Grarup (3)
  Karina Banasik (3)
  Mette Wod (1) (2)
  Torben J?rgensen (4) (5)
  Daniel R Witte (6)
  Torsten Lauritzen (7)
  Aneta A Nielsen (8)
  Ivan Brandslund (8) (9)
  Cramer Christensen (10)
  Oluf Pedersen (11) (12) (3)
  Knud Yderstr?de (1)
  Henning Beck-Nielsen (1)
  Jan Erik Henriksen (1)
  Torben Hansen (2) (3)
  Kurt H?jlund (1) (2)
  
• 关键词：Type 2 diabetes ; Genetics ; Insulin resistance ; Human ; Lipid droplets ; AGPAT6 ; GPAT4
• 刊名：BMC Medical Genetics
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：14
• 期：1
• 全文大小：325 KB
• 参考文献：1. Farese RV Jr, Walther TC: Lipid droplets finally get a little R-E-S-P-E-C-T. / Cell 2009, 139:855-60. CrossRef
  2. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. / Diabetes 1997, 46:983-88. CrossRef
  3. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, H?ring HU: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. / Diabetes 1999, 48:1113-119. CrossRef
  4. Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H: Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. / Diabetologia 2001, 44:824-33. CrossRef
  5. Virkam?ki A, Korsheninnikova E, Sepp?l?-Lindroos A, Vehkavaara S, Goto T, Halavaara J, H?kkinen AM, Yki-J?rvinen H: Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. / Diabetes 2001, 50:2337-343. CrossRef
  6. DeFronzo RA: Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard lecture 2009. / Diabetologia 2010, 53:1270-287. CrossRef
  7. Lettner A, Roden M: Ectopic fat and insulin resistance. / Curr Diab Rep 2008, 8:185-91. CrossRef
  8. Szendroedi J, Roden M: Ectopic lipids and organ function. / Curr Opin Lipidol 2009, 20:50-6. CrossRef
  9. Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S: Genetic syndromes of severe insulin resistance. / Endocr Rev 2011, 32:498-14. CrossRef
  10. Takeuchi K, Reue K: Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. / Am J Physiol Endocrinol Metab 2009, 296:E1195-E1209. CrossRef
  11. Chen YQ, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, Thibodeaux SJ, Chu S, Qian YW, Zhao Y, Bredt DS, Moller DE, Konrad RJ, Beigneux AP, Young SG, Cao G: AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. / J Biol Chem 2008, 283:10048-0057. CrossRef
  12. Nagle CA, Vergnes L, Dejong H, Wang S, Lewin TM, Reue K, Coleman RA: Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6??mice. / J Lipid Res 2008, 49:823-31. CrossRef
  13. Vergnes L, Beigneux AP, Davis R, Watkins SM, Young SG, Reue K: Agpat6 Deficiency causes subdermal lipodystrophy and resistance to obesity. / J Lipid Res 2006, 47:745-54. CrossRef
  14. Shan D, Li JL, Wu L, Li D, Hurov J, Tobin JF, Gimeno RE, Cao J: GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis. / J Lipid Res 2010, 51:1971-981. CrossRef
  15. Li D, Yu L, Wu H, Shan Y, Guo J, Dang Y, Wei Y, Zhao S: Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. / J Human Genet 2003, 48:438-42. CrossRef
  16. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C: A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. / Eur J Cardiovasc Prev Rehabil 2003, 10:377-86. CrossRef
  17. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. / Int J ObesRelat Metab Disord 2000,3(24 Suppl):S6-S11. CrossRef
  18. Albrechtsen A, Grarup N, Li Y, Spars? T, Tian G, Cao H, Jiang T, Kim SY, Korneliussen T, Li Q, Nie C, Wu R, Skotte L, Morris AP, Ladenvall C, Cauchi S, Stan?áková A, Andersen G, Astrup A, Banasik K, Bennett AJ, Bolund L, Charpentier G, Chen Y, Dekker JM, Doney AS, Dorkhan M, Forsen T, Frayling TM, Groves CJ, / et al.: Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. / Diabetologia 2013,56(2):298-10. CrossRef
  19. World Health Organisation: / Definition, diagnosis and classification of diabetes mellitus: report of a WHO consultation. Geneva, Switzerland: World Health Organisation; 1999. WHO/NCD/NCS/99.2
  20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. / Diabetologia 1985, 28:412-19. CrossRef
  21. Hansen T, Drivsholm T, Urhammer SA, Palacios RT, V?lund A, Borch-Johnsen K, Pedersen O: The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. / Diabetes Care 2007, 30:257-62. CrossRef
  22. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. / Diabetes Care 1999, 22:1462-470. CrossRef
  23. Stumvoll M, Van HT, Fritsche A, Gerich J: Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. / Diabetes Care 2001, 24:796-97. CrossRef
  24. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè AV, Steinthorsdottir V, Strawbridge RJ, Khan H, Grallert H, Mahajan A, Prokopenko I, Kang HM, Dina C, Esko T, Fraser RM, Kanoni S, Kumar A, Lagou V, Langenberg C, Luan J, Lindgren CM, Müller-Nurasyid M, Pechlivanis S, Rayner NW, Scott LJ, Wiltshire S, Yengo L, Kinnunen L, Rossin EJ, Raychaudhuri S, / et al.: Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. / Nat Genet 2012,44(9):981-90. CrossRef
  25. Taskinen MR: Diabetic dyslipidaemia: from basic research to clinical practice. / Diabetologia 2003, 46:733-49. CrossRef
  26. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PIW, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bostr?m KB, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Ohro-Melander M, R?stam L, Speliotes EK, Taskinen MR, Tuomi T, / et al.: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. / Science 2007, 316:1331-336. CrossRef
  27. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu T, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Saramies J, / et al.: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. / Science 2007, 316:1341-345. CrossRef
  28. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PIW, Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostr?m KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, / et al.: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. / Nat Genet 2008, 40:638-45. CrossRef
  29. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P: A genome-wide association study identifies novel risk loci for type 2 diabetes. / Nature 2007, 445:881-85. CrossRef
  30. Grarup N, Sparso T, Hansen T: Physiologic characterization of type 2 diabetes-related loci. / Curr Diab Rep 2010, 10:485-97. CrossRef
  31. Agarwal AK, Arioglu E, Almeida SD, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. / Nat Genet 2002, 31:21-3. CrossRef
  32. Cortes VA, Curtis DE, Sukumaran S, Shao X, Parameswara V, Rashid S, Smith AR, Ren J, Esser V, Hammer RE, Agarwal AK, Horton JD, Garg A: Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. / Cell Metab 2009, 9:165-76. CrossRef
  33. Johansen CT, Hegele RA: Genetic bases of hypertriglyceridemic phenotypes. / Curr Opin Lipidol 2011, 22:247-53. CrossRef
  34. Hucking K, Watanabe RM, Stefanovski D, Bergman RN: OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. / Obesity (Silver Spring) 2008, 16:1938-945. CrossRef
  35. Cohen JC, Horton JD, Hobbs HH: Human fatty liver disease: old questions and new insights. / Science 2011, 332:1519-523. CrossRef
  36. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O’Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS NASHCRN, Consortium GIANT, Investigators MAGIC, Voight BF, Carr JJ, Feitosa MF, / et al.: Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. / PLoS Genet 2011, 7:e1001324. CrossRef
  37. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/14/113/prepub
  
• 作者单位：Lena S?nder Snogdal (1) (2)
  Niels Grarup (3)
  Karina Banasik (3)
  Mette Wod (1) (2)
  Torben J?rgensen (4) (5)
  Daniel R Witte (6)
  Torsten Lauritzen (7)
  Aneta A Nielsen (8)
  Ivan Brandslund (8) (9)
  Cramer Christensen (10)
  Oluf Pedersen (11) (12) (3)
  Knud Yderstr?de (1)
  Henning Beck-Nielsen (1)
  Jan Erik Henriksen (1)
  Torben Hansen (2) (3)
  Kurt H?jlund (1) (2)
  
  1. Department of Endocrinology, Diabetes Research Center, Odense University Hospital, Odense, Denmark
  2. Section of Molecular Diabetes & Metabolism, Institute of Clinical Research & Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
  3. The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  4. Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
  5. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  6. Steno Diabetes Center, Gentofte, Denmark
  7. Department of General Practice, University of Aarhus, Aarhus, Denmark
  8. Department of Clinical Biochemistry, Vejle Hospital, Vejle, Denmark
  9. Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark
  10. Department of Internal Medicine and Endocrinology, Vejle Hospital, Vejle, Denmark
  11. Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark
  12. Hagedorn Research Institute, Gentofte, Denmark
  
• ISSN：1471-2350

文摘

Background Type 2 diabetes, obesity and insulin resistance are characterized by hypertriglyceridemia and ectopic accumulation of lipids in liver and skeletal muscle. AGPAT6 encodes a novel glycerol-3 phosphate acyltransferase, GPAT4, which catalyzes the first step in the de novo triglyceride synthesis. AGPAT6-deficient mice show lower weight and resistance to diet- and genetically induced obesity. Here, we examined whether common or low-frequency variants in AGPAT6 associate with type 2 diabetes or related metabolic traits in a Danish population. Methods Eleven variants selected by a candidate gene approach capturing the common and low-frequency variation of AGPAT6 were genotyped in 12,068 Danes from four study populations of middle-aged individuals. The case–control study involved 4,638 type 2 diabetic and 5,934 glucose-tolerant individuals, while studies of quantitative metabolic traits were performed in 5,645 non-diabetic participants of the Inter99 Study. Results None of the eleven AGPAT6 variants were robustly associated with type 2 diabetes in the Danish case–control study. Moreover, none of the AGPAT6 variants showed association with measures of obesity (waist circumference and BMI), serum lipid concentrations, fasting or 2-h post-glucose load levels of plasma glucose and serum insulin, or estimated indices of insulin secretion or insulin sensitivity. Conclusions Common and low-frequency variants in AGPAT6 do not significantly associate with type 2 diabetes susceptibility, or influence related phenotypic traits such as obesity, dyslipidemia or indices of insulin sensitivity or insulin secretion in the population studied.